Benjamin P. Saylor
Saylor is content managing editor for Urology Times.
High T linked to poor response to flu vaccine
Researchers say they have linked high testosterone levels in men to a poor immune response to an influenza vaccine.
Battle over integrated services related to urology shifts to states
Despite defeats of bills in several states, some urologists believe that threats to urologists' ability to provide ancillary services—essentially, their ability to furnish integrated health care—are not going away.
Conflicting robotic prostatectomy studies underscore robotics debate
Urologists attending localized prostate cancer sessions at the upcoming AUA annual meeting in Washington will hear more about the ongoing debate on open versus minimally invasive radical prostatectomy, the use of 5-alpha-reductase inhibitors (5-ARIs) in men on active surveillance, and updates on treatment approaches such as high-intensity focused ultrasound.
Stress urinary incontinence patients remain satisfied 7 years after surgery
Patient satisfaction with incontinence surgery remains high at a follow-up of up to 7 years despite declining continence rates over time, according to the authors of a large, multicenter study.
Two mid-urethral slings show similar efficacy in stress urinary incontinence
Transobturator and retropubic mid-urethral sling procedures appear to have equivalent efficacy but show different complications when used for the treatment of female stress urinary incontinence.
Minimally invasive technology for lower urinary tract symptoms safe, efficacious
A novel minimally invasive system for the treatment of lower urinary tract symptoms due to BPH appears to be safe and efficacious for as long as 2 years after the procedure is performed.
New research links LUTS, cardiometabolic disorders
Men with even mild lower urinary tract symptoms are at an increased risk of developing components of cardiometabolic disorders.
Research links cardiometabolic disorders, urologic disease
As research reveals more associations between cardiometabolic disorders and urologic disease, experts are emphasizing the importance of the urologist in detecting cardiometabolic risk factors in patients.
Regional expenditures for early-stage bladder cancer vary
Aggressive treatment for early-stage bladder cancer does not appear to benefit patients with the disease and may even increase the likelihood for later intervention compared with less-intensive treatment.